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subarachnoid hemorrhage
Khalid A HanafyAbstract
Background: Although microglia and the Toll-like receptor (TLR) pathway have long been thought to play a role in
the pathogenesis of aneurysmal subarachnoid hemorrhage (aSAH), thus far only correlations have been made. In
this study, we attempted to solidify the relationship between microglia and the TLR pathway using depletion and
genetic knockouts, respectively.
Methods: Subarachnoid hemorrhage was induced in TLR4−/−, TRIF−/−, MyD88−/− and wild type C57BL/6 mice by
injecting 60 μl of autologous blood near the mesencephalon; animals were euthanized 1 to 15 days after SAH for
immunohistochemical analysis to detect microglia or apoptotic cells. Lastly, microglial depletion was performed by
intracerebroventricular injection of clodronate liposomes.
Results: On post operative day (POD) 7 (early phase SAH), neuronal apoptosis was largely TLR4-MyD88-dependent
and microglial-dependent. By POD 15 (late phase SAH), neuronal apoptosis was characterized by TLR4- toll receptor
associated activator of interferon (TRIF)-dependence and microglial-independence. Similarly, vasospasm was also
characterized by an early and late phase with MyD88 and TRIF dependence, respectively. Lastly, microglia seem to
be both necessary and sufficient to cause vasospasm in both the early and late phases of SAH in our model.
Conclusion: Our results suggest that SAH pathology could have different phases. These results could explain why
therapies tailored to aSAH patients have failed for the most part. Perhaps a novel strategy utilizing
immunotherapies that target Toll like receptor signaling and microglia at different points in the patient’s hospital
course could improve outcomes.
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Aneurysmal subarachnoid hemorrhage (aSAH) is a devas-
tating disease that affects 30,000 Americans each year [1,2].
A total of 30 to 40% of these patients will have delayed
cerebral ischemia (DCI) from vasospasm, anywhere from 4
to 14 days after ictus, resulting in increased morbidity and
mortality [3]. Few studies have addressed the molecular
mechanisms that lead to DCI. The inciting event is the
release of oxyhemoglobin from red blood cell lysis in the
subarachnoid space [4,5]. The heme that is released from
hemoglobin results in a significant cerebral inflammatoryCorrespondence: khanafy@bidmc.harvard.edu
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reproduction in any medium, provided the orresponse [6]. To dissipate the heme burden, the resident
cerebral macrophage or microglia can engulf heme, as
demonstrated in mouse intracerebral hemorrhage models,
and degrade it via heme oxygenase [7,8]. Furthermore, in
primary macrophage culture, heme has been shown to be a
specific agonist for the Toll-like receptor 4 (TLR4) [9].
In both SAH patients and mouse models, TLR4 ex-
pression is up-regulated in the brain [10-12]. However,
little is known about the signal transduction that occurs
downstream of TLR4 to cause DCI or what cells mediate
DCI. That is, after stimulation of TLR4, the MyD88
(myeloid differentiation primary response gene) pathway
can facilitate further action by phosphorylation and ac-
tivation of IRAK4 (IL-1 receptor associated kinase 4),
which results in NF-kB-dependent inflammation [13].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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TRIF (toll receptor associated activator of interferon)
pathway [13]. TRIF signaling results in a delayed NF-
kB activation, similar to MyD88, and facilitates apop-
tosis [14].
The understanding of the immune cells involved in
DCI is in its infancy. Neutrophils may play a role in DCI
as systemic depletion resulted in improved cognitive per-
formance and decreased vasospasm; however, their role
in cerebral inflammation after SAH is likely indirect [15].
Neutrophils are not endogenous to the brain, nor do they
have a published role in aneurysm formation. Resident
macrophages of the brain, on the other hand, are first
responders to the deluge of heme after SAH, and are
necessary for aneurysm formation [9,16]. As of yet, no
causal relationship has been elucidated between macro-
phages and DCI. In this study, we show the critical role
that microglia play in facilitating vasospasm and neuronal
apoptosis. Furthermore, we establish a temporal role for
the TLR4 pathway in the induction of apoptosis and
vasospasm using both in vivo and in vitro models.
Materials and methods
Materials
Hemin was purchased from Sigma Aldrich (St. Louis, MO,
USA) and dissolved in dimethyl sulfoxide (DMSO).
Animals
All animal experiments were approved for use by the Beth
Israel Deaconess Medical Center Institutional Animal Care
and Use Committee and performed in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals. All mice were 10- to 12-week-old
males on a C57BL/6 background: TLR4−/−, MyD88−/−,
TRIF−/− and wild type (Jackson Laboratory, Bar Harbor,
ME, USA).
Primary microglial culture
This method is described in detail elsewhere [17]. Briefly,
microglia were harvested from neonatal mice (P0-P5) using
the Papain Dissociation System (Worthington Biomedical
Corporation, Lakewood Township, NJ, USA). The tissue
was minced and triturated, then incubated at 37°C for
one hour. The suspension was subjected to a discon-
tinuous gradient separation, followed by re-suspension
in DMEM-10% FBS containing 1 ng/ml macrophage
colony-stimulating factor (M-CSF). The flask was intermit-
tently shaken over the next two to three weeks to obtain a
confluent microglial culture.
TNF-α ELISA
Primary microglial culture was incubated with 40 μm hemin
for 24 hours and TNF-α was measured in supernatant per
protocol from BD Biosciences (San Jose, CA, USA).In vitro vasospasm
C57BL/6 mice were anesthetized with isoflurane followed
by careful dissection of a 3 cm length of the descending
aorta. The aorta was then secured to a vibrotome
(Leica Biosystems, Buffalo Grove, IL, USA) plate with
glue and 100 μm thick slices were acquired. The aortic
slices were incubated in modified Krebs-Henseleit solu-
tion containing (mmol/L): NaCl 120, KCl 4.5, MgSO4 1,
NaHCO3 27, KH2PO4 1, CaCl2 2.5 and dextrose 10.
The rings were equilibrated for 90 minutes at 37°C 5%
CO2 and the medium was replaced every 20 minutes,
as described previously [18].
In vitro and in vivo vasospasm measurement
Coronal cross sections were dehydrated using alcohol
and stained with hematoxylin and eosin for in vivo slices.
In vitro slices of mouse aorta were imaged directly.
Images were acquired with Spot Advanced Software
(SPOT Imaging Solutions, Sterling Heights, MI, USA).
Using measurement tools provided in the software, the
inner and outer perimeters were measured and the lumen
radius to wall thickness ratio was calculated from these
measurements. Three consecutive slices were measured
and averaged to obtain the final lumen to wall ratio.
SAH
The subarachnoid hemorrhage model was previously
described with several modifications detailed below
[19]. Mice were anesthetized with xylazine (10 mg/kg)
and ketamine (12 mg/kg) and placed in a stereotax where
a midline scalp incision was performed. A burr hole was
drilled 3.5 mm anterior to the bregma until dural penetra-
tion was achieved. A 27-gauge spinal needle was advanced
ventrally at 40° to a depth of 5 mm dorsoventral. A total
of 60 μl of arterial blood from a donor mouse was injected
over 10 seconds.
ICV injections
Mice were anesthetized as described above. Two burr
holes were drilled 0.22 mm posterior to the bregma,
1 mm lateral, and 2.25 mm in depth to enter the bilateral
ventricles. Pulled glass capillaries were used to inject 8
μl of clodronate (a generous gift provided by Prof. Reto
Schwendener) or PBS liposomes were divided equally
between the ventricles, over 12.5 minutes. The capil-
laries were held in place for 2.5 minutes thereafter to
prevent any regurgitation, followed by skin closure.
Intracerebroventricular (ICV) injections were performed
on post-operative days (PODs) 1 to 2 after SAH procedure.
ICV injections of 5 μg of LPS (lipopolysaccharide) at a
concentration of 1 μg/μl were performed at the coordi-
nates noted above in the right lateral ventricle only, as
previously described [20]. No SAH surgeries were done
in these mice.
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Adult male C57BL/6 were sedated with an Avertin over-
dose (250 mg/kg), followed by perfusion with ice-cold PBS.
The brains were fixed and then cut into 12 μm coronal ser-
ial sections with a Leica CM3050 S cryostat. TUNEL stain-
ing was performed as per instructions (Roche Diagnostics,
Indianapolis, IN, USA). Primary antibodies for Isolectin B1
(Sigma-Aldrich, St. Louis, MO, USA), Glial Fibrillary Acidic
Protein (Dako, Carpinteria, CA, USA Toll-like receptor
4 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), or
β-III Tubulin (Abcam, Cambridge, MA) were applied
at a dilution of 1:250, followed by secondary incubation
with Alexa Fluor antibodies at a dilution of 1:250. Fluor-
escent microscopy was done on a Zeiss Axio Scope
(Carl Zeiss, Inc., Thornwood, NY, USA). Brightness and
contrast of images were adjusted in Image J software
(National Institutes of Health, USA).
Statistics
Continuous variables were assessed for normality with
skewness and kurtosis. All variables measured in this
study were normally distributed and groups were comparedFigure 1 Vasospasm time course in subarachnoid hemorrhage model
middle cerebral artery (MCA) in sham from post-operative day (POD) 7. Sca
hemorrhage (SAH) induction on POD 7. C. Shows a diagram of the corona
analysis. D. Lumen radius/wall thickness was measured to determine the d
significant differences between sham and SAH were noted for POD 3, 7, 10
Error bars are standard deviations and N = 4 per group.with the Student’s t-test or ANOVA. If comparisons were
made among groups analyzed by ANOVA, the Bonferroni
correction was used. All statistical analyses were performed
using SPSS 19 software (SPSS Inc., Chicago, IL, USA).
P <0.05 was considered statistically significant.
Results
To determine the optimal time to visualize vasospasm,
we performed a time course of subarachnoid hemorrhage
from PODs 1 through 15 (Figure 1). The dimensions of the
middle cerebral artery were analyzed at the level of the
hippocampus for consistency, as shown in Figure 1C. We
found that the difference between sham and wild type (WT)
SAH vasospasm was maximal on days 3 and 10. There was
no difference between sham and WT SAH on POD 5, indi-
cating resolution of vasospasm by Day 5, followed by de-
layed vasospasm beginning on Day 7 and plateauing on Day
10 (Figure 1). To determine if neuronal cell death correlated
with vasospasm in our model, we quantified TUNEL posi-
tive cells from days 1 through 15 in the dentate gyrus of the
hippocampus. Similarly, cell death also had a bimodal distri-
bution, peaking on PODs 7 and 15 (Figure 2).. A. Hematoxylin and Eosin (H&E) stain of coronal section through
le Bars are all: 10 μm. B. H&E of MCA stain after subarachnoid
l section where MCA dimensions were measured for vasospasm
egree of vasospasm. Student’s t-test was done for each POD and
and 15 with P-values of <0.001, <0.04, <0.001 and <0.01, respectively.
Figure 2 Neuronal apoptosis time course in subarachnoid hemorrhage model. A. Merge of DAPI and TUNEL staining in sham and
subarachnoid hemorrhage (SAH) along entire time course from post-operative days (PODs) 1 to 15. Scale Bar: 10 μm. B. Nissel stain from atlas.
brain-map.org showing specific area of dentate gyrus that was used for quantification of neuronal apoptosis. C. Apoptotic neurons quantified in
dentate gyrus on each POD. Student’s t-test for each POD showed significance between sham and SAH on POD 5 (P <0.02), 7 (P <0.0001),
10 (P <0.01) and 15 (P <0.0001). Error bars are standard deviations and N = 4 per group.
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death was maximal at these two time points, and it cor-
related well with human vasospasm peaking on post-
bleed Day 7, with continued risk of vasospasm through
post-bleed Day 14 [21]. We then set out to determineFigure 3 Quantification of vasospasm and neuronal apoptosis at POD
radius/wall thickness on post-operative days (PODs) 7 and 15 in sham, intra
subarachnoid hemorrhage (SAH), TLR4−/− SAH, MyD88−/− SAH, and TRIF−
POD 15 in Myd88−/− (P <0.01) and TRIF−/− on POD 7 (P <0.02). No differe
and MyD88−/− on POD 15. For A and B, error bars are standard deviations
gyrus at PODs 7 and 15 in sham, ICV-injected LPS, wild type SAH, Toll-like r
t-test on POD 7 resulted in significantly increased neuronal apoptosis in TR
significant increase in neuronal apoptosis exists between wild type (WT) SA
No difference between wild type SAH and TRIF−/− on POD 7 or wild typethe role of the TLR4 signaling cascade as it relates to
vasospasm and neuronal apoptosis on PODs 7 and 15
(Figure 3). On PODs 7 and 15, vasospasm in the WT SAH
was significantly increased compared to the TLR4−/− SAH
(Figure 3A). Intracerebroventricular injection of LPS, as 7 and 15 in the TLR4 pathway. A. Vasospasm quantified by lumen
cerebroventricular (ICV)-injected lipopolysaccharide (LPS), wild type
/− SAH. Student’s t-test showed significantly increased vasospasm on
nce between wild type SAH and TRIF−/− on POD 7 or wild type SAH
and N = 4 for each group. B. Apoptotic neurons quantified in dentate
eceptor 4 (TLR4)−/− SAH, MyD88−/− SAH, and TRIF−/− SAH. Student’s
IF−/− (P <0.03) and in MyD88−/− on POD 15 (P <0.04). Furthermore, a
H and ICV LPS on POD 7 by Bonferroni post-hoc comparison (P <0.04).
SAH and MyD88−/− on POD 15.
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to the WT SAH on both PODs 7 and 15 [22]. Furthermore,
when comparing SAH in MyD88−/− to TRIF−/−, vaso-
spasm was significantly greater in the TRIF−/− on POD
7, while the opposite was true at POD 15. Of note, when
comparing maximal vasospasm on PODs 7 and 15, there
was no difference between WT SAH and TRIF−/− SAH on
POD 7, and WT SAH and MyD88−/− SAH on POD 15.
Minimal vasospasm was seen in the sham and TLR4−/−
SAH on both days.
Additionally, we measured neuronal apoptosis in these
groups, as described in Figure 2. Interestingly, TRIF−/−Figure 4 Immunohistochemistry of TLR4 co-localization among the d
four mice per group and four different fields of view on post-operative day
receptor 4 (TLR4) in the first panel, Iba1 (for microglia) in the second panel
Immunohistochemistry showing individual panels and merge for astrocytes
Tubulin reflecting co-localization of TLR4 and neurons. Scale Bars: 15 μm. D
POD 7 and POD 15 showing microglia express the most Toll-like receptor 4SAH had a statistically equivalent neural apoptotic bur-
den to WT SAH on POD 7, while on POD 15, there was
no difference between MyD88−/− SAH and WT SAH.
In terms of minimal apoptotic burden, there was no differ-
ence between the number of apoptotic neurons quantified
in sham, TLR4−/− SAH, and MyD88 −/− SAH on POD 7.
At POD 15, there was no difference between the number
of apoptotic neurons quantified in sham, TLR4−/− SAH
and TRIF−/− SAH (Figure 3B). Of note, the LPS injected
mice, demonstrated significantly less neuronal apoptosis
at POD 7, compared to WT SAH; however at POD 15
there was no difference between these groups. With theifferent cell types of the murine brain. Representative images from
(POD) 7 A. Immunohistochemistry across shows staining with Toll-like
, and the merge in the third panel. Arrows delineate co-localization. B.
with Glial Fibrillary acidic protein. C. Immunohistochemistry for β III
. Quantification based on four mice and four different fields of view at
(TLR4) by ANOVA at both time points (P <0.001).
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vasospasm and neuronal apoptosis, we wanted to identify
what type of cell was expressing TLR4. Microglia, astro-
cytes and neurons were examined for TLR4 expression
with representative images shown in Figure 4A-C and
quantification of TLR4 co-localization in Figure 4D. Based
on these results, we found that the majority of TLR4 is
expressed in microglia at both POD 7 and 15 after SAH.
To further elucidate the relationship between micro-
glia and vasospasm, we modified an in vitro assay [18]
where we incubated neonatal primary microglial (PMG)
culture with hemin for 24 hours to simulate the in vivo
environment after subarachnoid hemorrhage. After 24
hours, the supernatant from the cultures was taken and
incubated with axial sections of wild type mouse aortic
rings for 5 minutes and vasospasm was measured. PMG
from all genotypes, except the TLR4−/− mice, were able
to induce vasospasm and secrete TNF-α (Figure 5A, B).
Based on these results, the TLR4 receptor is necessary
for microglia to secrete some factor into the media
that causes vasospasm in mouse aortic slice culture. To
exclude endotoxin contamination in our hemin prepar-
ation, endotoxin was measured by ELISA and found to
be <0.001 ng/μl (data not shown).
The in vitro data suggest that the microglial TLR4 re-
ceptor is necessary for vasospasm, as well as the in vivo
data which indicate that the TLR4 receptor is necessary
for vasospasm. To resolve whether microglia are neces-
sary for vasospasm in vivo, we depleted microglia in vivo
via intraventricular injection of clodronate liposomes into
WT SAH. Immunohistochemistry for microglia shows
virtually complete depletion with clodronate compared
to PBS liposomes (Figure 6A-C). Additionally, whenFigure 5 In vitro vasospasm assay and cytokine production in respon
5-minute incubation with supernatant from primary microglial cell culture
exposed to one mouse aortic ring and this was repeated four times. Error b
supernatant after 24 hours of hemin exposure. This was repeated four time
between wild type (WT), TRIF−/−, and MyD88−/− PMG per the Bonferroni
were significant (P <0.03, P <0.02, respectively).vasospasm was measured at PODs 7 and 15, the depletion
of microglia with clodronate resulted in significant amelior-
ation of vasospasm at both time points (Figure 6D).
Finally, we determined whether microglial depletion
effected neuronal apoptosis in Figure 7, and found a
similar bimodal theme. At POD 7, the depletion of
microglia resulted in a significant decrease in neuronal
apoptosis (Figure 7A, C); while at POD 15, microglial
depletion had no effect (Figure 7B, D).
Discussion
In this study, we have elucidated possible roles for micro-
glia and the TLR4 pathway with respect to vasospasm and
neuronal apoptosis. Many have suggested a role for TLR4
in SAH and more recently a modulatory role for peroxi-
some proliferator-activated receptor gamma (PPAR-γ)
via the TLR4 pathway [10-12,23]. However, our study
is unique in that we attempted to ascertain the roles of dif-
ferent signaling pathways downstream of TLR4 activation
and followed the mice out to 15 days to better parallel the
human condition where delayed cerebral ischemia can
occur up to 21 days from ictus [24].
It is interesting that two phases of vasospasm were
observed, one beginning on POD 3, resolving by POD 5,
and then another phase beginning on POD 7 and plat-
eauing by Day 10 (Figure 1). This is important to note
because it is similar to the human condition in that
vasospasm is bimodal, with an early ictal phase followed
by a delayed phase; it is the delayed vasospasm that is
associated with increased neuronal cell death or delayed
cerebral ischemia (DCI) [3,21,25].
Furthermore, our in vivo immunohistochemistry data
suggest that TLR4 is necessary for neuronal apoptosis.se to hemin. A. In vitro vasospasm of mouse aortic ring slice after
(PMG) exposed to 40 μM hemin for 24 hours. Each PMG culture was
ars are standard deviations. B. TNF-α was measured in the PMG
s to get standard deviations in this graph. No difference was seen
correction. One way ANOVA for both vasospasm and TNF-α secretion
Figure 6 The effects of microglial ablation on vasospasm. A. Top panels: microglial staining with Iba1 at the level of the hippocampus of
wild type subarachnoid hemorrhage SAH on post-operative days (PODs) 7 and 15 after intracerebroventricular (ICV) injection of control PBS
liposomes. B. Bottom panels: microglial depletion in wild type SAH on PODs 7 and 15 after ICV injection with clodronate liposomes. Scale Bars:
10 μm in all panels. C. Quantification of microglial cells in the hippocampal area of wild type SAH mice with ICV injections of PBS liposomes and
clodronate liposomes. N = 3 for each group and error bars are standard deviations. Comparison by Student’s t-test on POD 7 and POD 15
between clodronate and PBS liposomes injections shows significant depletion on both days (P <0.03). D. Measurement of vasospasm shows
significant ablation of vasospasm at both time points after microglial depletion by Student’s t-test: POD 7 (P <0.001) and POD 15 (P <0.001).
N = 3 mice for each group.
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WT SAH and TRIF−/− SAH was significantly greater
than that seen in LPS on POD 7, despite equivalent de-
grees of vasospasm (Figure 3). On POD 7, one can infer
that some product from red blood cell breakdown is
able to induce increased cell-death in the dentate gyrus
through the TLR4-MyD88 pathway and downstream
signal transduction systems that LPS cannot; however,
an insufficient amount of LPS could also be the case.
Because there was no difference between neuronal apop-
tosis and vasospasm in WT SAH and TRIF−/− SAH at
POD 7, we conclude that some portion of the neuronal
damage and vasospasm occurring on POD 7 (early SAH)is TLR4-MyD88-dependent. Likewise, because there
was no difference between neuronal apoptosis and
vasospasm observed in WT SAH, MyD88−/− SAH and
LPS on POD15, neuronal damage and vasospasm on POD
15 (late SAH) are largely TLR4-TRIF-dependent. Based on
our results in Figure 3, we see that vasospasm is, for the
most part, directly correlated with neuronal apoptosis.
Given that vasospasm is either constant or increasing
with time, it is expected that the apoptotic burden will
not change or decrease only slightly as resolution of the
insult occurs. The exception is the TRIF−/− SAH where
vasospasm decreases with time and, therefore, we be-
lieve that the clearance of the apoptotic burden results
Figure 7 The effects of microglial ablation on neuronal apoptosis. A. Top panel: merge of DAPI and TUNEL staining from dentate gyrus of
wild type subarachnoid hemorrhage (SAH) after intracerebroventricular (ICV) PBS liposome injection on POD 7 and 15. B. Bottom panel: merge of
DAPI and TUNEL staining in wild type SAH after ICV clodronate injection on POD 7 and 15. Scale Bars: 10 μm in all panels. C. Quantification of
apoptotic neurons on POD 7 displaying significant reduction, by Student’s t-test (P <0.03), after ICV clodronate injection and microglial ablation.
D. Quantification of apoptotic neurons on POD 15 revealing no change between ICV PBS and clodronate injections. N = 3 for each group and
error bars are standard deviations.
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the temporal relationship between TLR4-MyD88 activa-
tion and TLR4-TRIF activation is not unprecedented.
Expression of NF-kB is seen in two phases after LPS
stimulation of TLR4 [14]. MyD88 is responsible for the
early phase and TRIF, the later phase, similar to our re-
sults. Because the role for microglia in DCI and SAH is
largely unknown with respect to TLR4, we performed
immunohistochemistry to verify that microglia do indeed
express a majority of TLR4 in vivo after SAH at both POD
7 and 15. Although astrocytes and neurons express less
TLR4, their role in DCI and cerebral inflammation may
still be significant (Figure 4). To verify the relationship
between the TLR4 pathway and microglia with respect to
vasospasm, we performed in vitro vasospasm assays that
confirmed a necessary role for the TLR4 receptor (Figure 5).
While other groups have implicated microglia and heme inthe pathogenesis of intracerebral hemorrhage and shown
that TLR4−/− was protective, the downstream mediators
of TLR4 were never examined with respect to cytokine
production or vasospasm [26].
We found that the TRIF and MyD88 pathways elicited
equal degrees of vasospasm, as well as TNF-α secretion,
compared to WT microglia. Because vasospasm and TNF-α
secretion were not additive in WT microglia stimulated
by heme, the temporal theme of sequential activation of
MyD88 and TRIF is supported, although not necessarily
in that order based on this in vitro experiment. A plateau
effect is also possible where despite simultaneous activa-
tion of the MyD88 and TRIF pathways in WT microglia,
the mouse aortic slice cannot constrict further. The other
possible explanation is that the determination of the dom-
inant pathway is influenced by the external chemical and
cellular milieu of the brain, which is lacking in culture.
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vasospasm and neuronal apoptosis, we depleted microglia
using clodronate liposomes and showed that in both early
and late phases of SAH, microglia are necessary for vaso-
spasm. Also of note, neuronal apoptosis was abrogated by
microglial depletion in early SAH only (Figure 7). With
respect to a role for microglia in SAH, to our knowledge,
we are the first to effectively deplete this specific cell type
in the brain and demonstrate a functional response. Others
have noted proliferation and activation of microglia
after hemorrhagic stroke, specifically SAH and intracerebral
hemorrhage [26,27]. Interestingly, in hemorrhagic stroke,
microglia seem to be detrimental by some accounts,
whereas in neonatal stroke and neurodegenerative diseases
they have a more beneficial role [26,28,29]. The caveat is
that effects of microglial depletion were only examined at
one time point after depletion. Perhaps, if other time points
after microglial depletion had been studied, the role of
microglia in the pathogenesis of these diseases would also
change with time.
Taken together, our model suggests that there could be
different phases of SAH. The early phase of SAH, where
neuronal apoptosis is largely TLR4-MyD88-dependent
and microglial-dependent, followed by a late phase that is
characterized by a TLR4-TRIF dependent, microglial-
independent neuronal apoptosis. Furthermore, vasospasm
is characterized by an early and late phase response that
depends on MyD88 and TRIF, respectively. Finally, micro-
glia seem to be both necessary and sufficient to cause
vasospasm in both the early and late phases of SAH, based
on our in vitro and in vivo models (Figures 5 and 6).
These findings may explain why therapies tailored to
aSAH patients have failed for the most part. If these data
can be translated to the SAH patient population, novel
immunotherapies could be conceived that target different
components of Toll like receptor signaling and microglia at
different points in the patient’s hospital course to alleviate
the cerebral inflammatory burden and improve outcomes.
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